TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
JAMCO Pharma Consulting AB
Closing information (x1000 NOK)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover | 6,479 | 5,855 | 4,851 |
Financial expenses | 0 | 339 | 5 |
Earnings before taxes | 4,498 | 3,626 | 3,344 |
EBITDA | 4,104 | 1,894 | 3,262 |
Total assets | 21,798 | 17,460 | 13,604 |
Current assets | 8,493 | 7,605 | 4,629 |
Current liabilities | 2,805 | 1,838 | 773 |
Equity capital | 18,669 | 14,732 | 12,021 |
- share capital | 49 | 48 | 50 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency | 85.6% | 84.4% | 88.4% |
Turnover per employee | 3,240 | 2,928 | 2,426 |
Profit as a percentage of turnover | 69.4% | 61.9% | 68.9% |
Return on assets (ROA) | 20.6% | 22.7% | 24.6% |
Current ratio | 302.8% | 413.8% | 598.8% |
Return on equity (ROE) | 24.1% | 24.6% | 27.8% |
Change turnover | 493 | 1,200 | 249 |
Change turnover % | 8% | 26% | 5% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.